Research is being conducted on precision medicine in severe asthma, focusing on practical phenotyping and evidence-based selection of biologic therapy. The use of biomarkers, machine learning, and other approaches is being explored to optimize treatment and improve patient outcomes. Studies are also examining the evolution of phenotypes in severe asthma and the potential of various therapies, including biologics and immunologic pathway targeting.